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Host microenvironmentThe tumor hostmicroenvironment is increasingly viewed as an important contributor to tumor growth and sup-
pression. Cellular oxidative stress resulting from high levels of reactive oxygen species (ROS) contributes to var-
ious processes involved in the development and progress ofmalignant tumors including carcinogenesis, aberrant
growth, metastasis, and angiogenesis. In this regard, the stroma induces oxidative stress in adjacent tumor cells,
and this in turn causes several changes in tumor cells including modulation of the redox status, inhibition of cell
proliferation, and induction of apoptotic or necrotic cell death. Because the levels of ROS are determined by a
balance between ROS generation and ROS detoxiﬁcation, disruption of this systemwill result in increased or de-
creased ROS level. Recently, we demonstrated that the control of mitochondrial redox balance and cellular de-
fense against oxidative damage is one of the primary functions of mitochondrial NADP+-dependent isocitrate
dehydrogenase (IDH2) that supplies NADPH for antioxidant systems. To explore the interactions between
tumor cells and the host, we evaluated tumorigenesis between IDH2-deﬁcient (knock-out) and wild-type mice
in which B16F10 melanoma cells had been implanted. Suppression of B16F10 cell tumorigenesis was reproduc-
ibly observed in the IDH2-deﬁcientmice alongwith signiﬁcant elevation of oxidative stress in both the tumor and
the stroma. In addition, the expression of angiogenesis markers was signiﬁcantly down-regulated in both the
tumor and the stroma of the IDH2-deﬁcient mice. These results support the hypothesis that redox status-
associated changes in the host environment of tumor-bearing mice may contribute to cancer progression.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Tumor growth, invasion, and metastasis depend not only on the
tumor cells but also on the complex interactions between the tumor
cells and host [1]. The tumor host microenvironment is increasingly
viewed as an important contributor to tumor growth and suppression
[2]. Most human carcinomas arise from neoplastic epithelial cells that
coexist with a variety of extracellular matrix components and cell
types, notably ﬁbroblasts, myoﬁbroblasts, adipocytes, endothelial cells,
pericytes, and immune cells, that collectively form the tumor stroma
[3–5]. Several lines of evidence have demonstrated that the tumor stro-
ma inﬂuences the growth, survival, invasiveness, and metastatic ability
of the neoplastic epithelial cells within these tumors [6,7]. Cellular oxi-
dative stress resulting from high levels of reactive oxygen species
(ROS) contributes to various processes involved in malignant tumor
growth and progression including carcinogenesis, aberrant growth,82 53 943 2762.
ights reserved.metastasis, and angiogenesis. Since ROS are usually increased in cancer
cells andROS do involve in initiation, progression andmetastasis of can-
cers, ROS are considered oncogenic [8]. On the other hand, high levels of
ROS, which can be achieved by various anti-cancer treatments, suppress
tumormetastasis by destroying cancer cells due to the oxidative nature
of ROS [9]. In this regard, the stroma induces oxidative stress in adjacent
tumor cells that in turn causes several changes in tumor cells including
modulation of the redox status, inhibition of cell proliferation, and in-
duction of apoptotic or necrotic cell death.
Because the level of ROS is determined by a balance between ROS
generation and ROS detoxiﬁcation, changes in this system will result
in increased or decreased ROS levels. Not only increased ROS production
but also reduced ROS detoxiﬁcation has been observed in conjunction
with tumor growth and metastasis [9]. Biological systems have evolved
an effective and complicated network of defense mechanisms that en-
able cells to cope with lethal oxidative environments. These defense
mechanisms involve antioxidant enzymes such as superoxide dismut-
ase (SOD), catalase, and peroxidases [10]. Mitochondrial manganese
SOD (MnSOD) [11] and glutathione peroxidase [12] serve as primary
defenses against ROS in mitochondria. Reduced glutathione (GSH)
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substrate for mitochondrial glutathione peroxidase and glutathione-
dependent phospholipid hydroperoxidase [13]. GSH levels inmitochon-
dria are maintained by NADPH-dependent glutathione reductase [14].
NADPH is also required for the regeneration of the thioredoxin system
that is essential for maintaining cellular thiol homeostasis [15]. Thus,
mitochondrial NADPH is fundamentally important for the defense
against ROS.
The isocitrate dehydrogenases (ICDHs; EC1.1.1.41 and EC1.1.1.42)
catalyze oxidative decarboxylation of isocitrate into α-ketoglutarate,
and require either NAD+ or NADP+ to produce NADH and NADPH,
respectively [16]. In mammals, there are three classes of ICDH
isoenzymes represented by mitochondrial NAD+-dependent ICDH,
mitochondrial NADP+-dependent ICDH (IDPm or IDH2), and cyto-
solic NADP+-dependent ICDH (IDPc or IDH1) [16]. We reported
that IDH2 helps supply NADPH needed for GSH production that con-
fers protection against mitochondrial oxidative damage [17]. In par-
ticular, IDH2 plays a very important part in the cellular defense
against oxidative stress by providing NADPH in the mitochondria
since glucose 6-phosphate dehydrogenase (G6PD) is not found in
mitochondria [17]. Considering the cytoprotective role of IDH2 and
potential vulnerability of themetastatic microenvironment to oxida-
tive stress, we speculated that tumorigenesis may be suppressed in
IDH2-deﬁcient mice. In addition, the role of IDH2 in reductive car-
boxylation glutaminolysis which is responsible for tumor survival
has been proposed [18].
To explore the interactions between tumor cells and the host, we
monitored tumorigenesis in IDH2-deﬁcient (knock-out, idh2−/−) and
wild-type (idh2+/+) mice in which B16F10 melanoma cells had been
implanted. Tumorigenesis of the B16F10 cells was reproducibly
suppressed in the IDH2-deﬁcient mice while oxidative stress in both
the tumor and the stromawas signiﬁcantly elevated. These results sup-
port the hypothesis that changes associated with redox status in the
host environment of tumor-bearing mice may contribute to cancer
progression.2. Materials and methods
2.1. Materials
β-NADP+, isocitrate, xylenol orange, 2,4-dinitophenylhydrazine
(DNPH), and 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB) were obtained
from Sigma Chemical Co. (St. Louis, MO). Antibodies were purchased
from Santa Cruz Biotechnology (Santa Cruz, CA) or Cell Signaling
(Beverly, MA). A peptide containing the 16 N-terminal amino acids of
mouse IDH2 (ADKRIKVAKPVVEMPG) was used to prepare polyclonal
anti-IDH2 antibodies [17].2.2. Establishment of a stable cell line expressing the ﬁreﬂy luciferase (Fluc)
gene
B16F10 mouse melanoma cells were grown in Dulbecco's modiﬁed
Eagle's medium supplemented with 10% (v/v) fetal bovine serum,
100 units/mL penicillin, and 100 μg/mL streptomycin at 37 °C in a
5% CO2/95% humidiﬁed atmosphere. The B16F10 cells were grown to
70–80% conﬂuency before being transfectedwith a recombinant lentivi-
rus bearing a plasmid containing both the ﬁreﬂy luciferase (Fluc) and
green ﬂuorescent protein (GFP) genes driven by a CMV promoter
(pLenti/CMV-Fluc-IRES-GFP). After transfection, the B16F10 cells
were cultured for several days and expression of the plasmid was
monitored according to the GFP signals with ﬂuorescent microscopy
(Nikon Eclipse Ti-S; Nikon Inc., Japan). Cells that expressed Fluc
and GFP proteins were selected by ﬂow cytometry (FACSorter; BD
Biosciences, San Jose, CA).2.3. Generation and characterization of idh2 knock-out mice
Genomic DNAwas extracted from129/SvJmouse J1 embryonic stem
cells andwas used as template DNA for PCR. A targeting vector was con-
structed to delete a 1170-bp genomic fragment containing a segment of
the N-terminal region of the idh2 gene using a 5′ 7.3-kb long arm frag-
ment and 3′ 2.4-kb short arm fragment ligated into a pPNT vector. The
neomycin phosphotransferase gene (neo) that conferred resistance to
the neomycin analog, G418, was used for positive selection. Herpes sim-
plex virus thymidine kinase (HSVtk), which conferred sensitivity to the
guanine analog, ganciclovir (GANC), was used for negative selection.
The targeting vector was linearized with Not1 and used to transfect
129/SvJmouse J1 embryonic stem cells via electroporation. Clones resis-
tant to G418 and GANC were selected, and homologous recombination
was conﬁrmed by Southern blotting. Among the 35 clones obtained, the
idh2 gene was successfully modiﬁed in ﬁve. To produce chimeric mice,
embryonic stem clones containing the targeted mutation were injected
into C57BL/6 blastocysts that were subsequently transferred to
recipient female mice on day 3 of pseudo-pregnancy. The resulting
male chimeric mice were bred with C57BL/6 females to obtain hetero-
zygous idh2mice. Germline transmission of the mutant allele was veri-
ﬁed by Southern blot analysis of tail DNA from F1 offspring with agouti
coat color. The heterozygous mice were interbred to generate homozy-
gous idh2-deﬁcientmice. For Southern blot analysis, a 1-kb probe located
just outside the 3′ short arm of the knock-out vector was prepared using
two primers (forward primer, 5′-TGCCTCCACCTTCTTAGTAGG-3′;
reverse primer, 5′-ACTAACGGATGGCATCAGCAG-3′). Mouse genomic
DNA was isolated from mouse tail samples, digested with SphI, and
hybridized with the probe.
2.4. Animal protocol
Animal studies were conducted in accordance with the institutional
guidelines for the care and use of laboratory animals. B16F10 cells
(1 × 105/0.1 mL PBS) were subcutaneously injected into the right
thigh of C57BL/6 wild-type (WT) and idh2 knock-out (KO) mice that
were divided into four groups (WT, WT + 5 Gy, KO, and KO + 5 Gy)
containing 5–6 mice in each group. Tumor volumes were measured
every 2 days and calculated (in mm3) according to the formula: short
size2 × long size / 2. The animals were euthanized 1 week after
receiving whole body irradiation with a 137Cs source at a dose rate of
1 Gy/min. Primary tumors in the ﬂank were excised, snap-frozen in liq-
uid nitrogen, and stored at−80 °C.
2.5. Preparation of tissue extracts
Tissues from themicewere homogenizedwith a solution containing
0.3 M sucrose, 25 mM imidazole, 1 mM EDTA (pH 7.2), 8.5 μM
leupeptin, and 100 μg/mL aprotinin using a homogenizer at maximum
speed for 15 s. Each homogenate was then centrifuged at 4000 ×g for
15 min at 4 °C. The resulting supernatants were stored at−20 °C be-
fore use. The protein concentrations were measured by the Bradford
method using reagents purchased from Bio-Rad (Hercules, CA).
2.6. Bioluminescence imaging analysis
Bioluminescence imaging of the mice was performed using an IVIS
Lumina II (Caliper Life Sciences, Hopkinton, MA) with a highly sensitive
CCD camera mounted on a light-tight specimen chamber. D-luciferin
potassium salt (Caliper Life Sciences, Hopkinton, MA) was diluted to
3 mg/100 μL in PBS before use, and 100 μL of this solution was injected
intraperitoneally into themice. After 10 min, themicewere placed indi-
vidually in the specimen chamber and light emitted by the luciferase
was measured. Grayscale photographic images and bioluminescent
color images were superimposed using LIVINGIMAGE, version 2.12
(Xenogen, Alameda, CA), and IGOR image analysis FX software
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in units of photons per cm2 per second per steradian (P/cm2/s/sr). To
quantify the emitted light, regions of interest (ROIs) were drawn over
the tumor region and total photon efﬂux over an exposure time of 1 s
was evaluated.
2.7. RNA isolation and reverse transcription (RT)-PCR
RNA was isolated using an RNeasy kit (Qiagen, Hilden, Germany)
according to the manufacturer's instruction. Total RNA (1 μg) was
reverse-transcribed into cDNA using a ﬁrst-strand cDNA synthesis kit
(Invitrogen, Carlsbad, CA) according to the manufacturer's protocol.
The cDNA template was then ampliﬁed by RT-PCR using a Perkin–
Elmer GeneAmp PCR System 2400 (Perkin–Elmer Cetus, Waltham,
MA) according to themanufacturer's protocol. Sequences of the primers
usedwere as follows: β-actin, forward 5′-TCTACAATGAGCTGCGTGTG-3′,
reverse 5′-ATCTCCTTCTGCATCCT-GTC-3′; IDH2, forward 5′-ATCAAGGA
GAAGC-TCATCCTGC-3′, reverse 5′-TCTGTGGCCTTGTACTGGTCG-3′; vas-
cular endothelial growth factor (VEGF) forward 5′-ACTTGTGTTGGGAG
GAGGATGTC-3′, reverse 5′- AATGGGTTTGTCGTGTTTCTGG-3′; HIF-1α,
forward 5′- TCATCAGTTGCCACTTCCCCAC-3′, reverse 5′- CCGTCATCTG
TTAGCACCATCAC-3′;Glut-1, forward 5′- GACCCTGCACCTCATTGG -3′, re-
verse 5′- GATGCTCAGATAGGACATCCAAG -3′; βFGF, forward 5′-CCCGAC
GGCCGCGTGGAT-3′, reverse 5′- ACTTAGAAGCCAGCAGCCG-3′. β-Actin
was used as an internal control. Each PCR reaction contained 1× SYBR
Premix Ex Taq, 0.2 μM of each primer, and 2 μL of a 1:5 dilution of the
cDNA in a ﬁnal volume of 20 μL. The following PCR program wasSphI
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was quantiﬁed using the second derivative maximummethods of Light
Cycler Software ver. 4.0 (Roche Diagnostics, Indianapolis, IN).
2.8. Immunoblot analysis
Proteins were separated in an 8–12.5% SDS-polyacrylamide gel,
transferred to nitrocellulose membranes, and subsequently subjected
to immunoblot analysis using the appropriate antibodies. Antibody
binding was then detected with an enhanced chemiluminescence de-
tection kit (AmershamPharmacia Biotech, Buckinghamshire, UK). Anal-
ysis of the blot images was performed with ImageJ software using the
“Gel Analysis” function.
2.9. Measurement of cellular redox status and oxidative damage
NADPH was measured using the enzymatic cycling method as de-
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Fig. 2. B16F10 melanoma growth in IDH2 knock-out mice. (A) Growth curve showing the average melanoma size for each group. Tumor volumes were measured with a digital caliper
every 2 days. Tumor volume (mm2) was calculated with the formula: short size2 × long size / 2. Each value represents the mean ± S.D. from ﬁve or six independent experiments.
(B) Average tumor volumes for the idh2+/+ and idh2−/−mice exposed to 5 Gy of ionizing radiation (IR). Tumor volumes were determined at the time of sacriﬁce. Each value represents
the mean ± S.D. from ﬁve or six independent experiments. *p b 0.01 versus the non-irradiated idh2+/+ mice. (C) Average tumor weights for the idh2+/+ and idh2−/−mice exposed to
5 Gy of IR. Tumor weights were determined at the time of sacriﬁce. Each value represents the mean ± S.D. from ﬁve or six independent experiments. *p b 0.01 versus the non-
irradiated idh2+/+ mice.
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A Protein Carbonyl Assay Kit (Cayman Chemical, Ann Arbor, MI) was
used to measure protein carbonyl contents in the cell lysates. This kit
measured the reaction between DNPH and protein carbonyls. The
amount of protein-hydrazone produced was quantiﬁed spectrophoto-
metrically at an absorbance between 360 and 385 nm. The carbonylA
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Fig. 4. Redox status and oxidative damage in tumor tissues from idh2+/+ and idh2−/−
mice. (A) Production of H2O2 in tumors from mice exposed to IR was measured with
xylenol orange. Each value represents the mean ± S.D. from ﬁve to six independent ex-
periments. *p b 0.01 versus non-irradiated idh2+/+ mice. (B) Protein carbonyl contents
of tumors frommice exposed to IR. The level of protein carbonyls wasmeasured in cell ly-
sates with DNPH. Each value represents themean ± S.D. from ﬁve or six independent ex-
periments. *p b 0.01 versus non-irradiated idh2+/+ mice. (C) The level of MDA
accumulated in tumor tissue extracts was determined using a TBARS assay. Each value
represents the mean ± S.D. from ﬁve or six independent experiments. *p b 0.01 versus
non-irradiated idh2+/+mice. (D) 4-HNE adducts in the tumor tissue extracts were moni-
tored with an anti-HNE Michael adduct antibody.
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roacetic acid) and heated at 100 °C for 15 min. The reaction was then
stopped by incubating on ice, and the absorbance was measured at
535 nm. Malondialdehyde (MDA) production in the samples was
evaluated using a spectrophotometric assay for TBARS as previously de-
scribed [20]. Lipid peroxidation in tissues was also measured with anti-
HNE Michael adduct antibody after SDS-PAGE as previously described
[21].
2.10. 2-DE, in-gel tryptic digestion, and protein identiﬁcation by mass
spectrometry (MS)
2-DE was performed with an Ettan IPGphor Isoelectric Focusing
(IEF) System (Amersham Pharmacia Biotech) using 24 cm, pH 4–10
nonlinear and pH 4–7 Immobiline Dry Strips for ﬁrst-dimensional sep-
aration, and 10–16% SDS-polyacrylamide gradient gels for the second
dimension. SDS-PAGEwas performed in an EttanDALTsix Large Vertical
System (Amersham Pharmacia Biotech). Spots of interest were excised
and in-gel digestion was subsequently performed with 20 mL of
50 mM H4HCO3 (pH 8.0) containing 20 mg/mL trypsin (Promega,
Madison, WI). MALDI-TOF MS was performed using an Applied
Biosystems 4700 proteomics analyzer (Applied Biosystems, Foster
City, CA) in the reﬂector/delayed-extraction mode. Proteins were iden-
tiﬁed according to peptide mass ﬁngerprint (PMF) using the Swiss-Prot
(updated 30/03/2010) and NCBInr (updated 30/03/2010) databases
with a special search tool [MS-FIT from Protein Prospector V 5.6.1
(http://prospector.ucsf.edu)].
2.11. Measurement of serum VEGF with an ELISA
Mice were euthanized and blood was obtained by cardiac puncture.
Serum was recovered from the blood by centrifugation in a BD
Microtainer SST Tube at 10,000 ×g for 90 s. VEGF concentrations in
the serum (50 μL) were analyzed using a mouse VEGF ELISA kit
(Quantikine R & D Systems, Minneapolis, MN) according to the
manufacturer's protocol.
2.12. Statistical analysis
Differences between two mean values were analyzed by Student's
t-test. p-Values b 0.05 were considered to be statistically signiﬁcant.
2.13. Replicates
Unless otherwise indicated, all results described in this paper are
representative of at least three separate experiments.
3. Results and discussion
3.1. Identiﬁcation of IDH2 knock-out mice
IDPm plays an essential role in cellular defense against oxidative
damage by supplying NADPH in themitochondria. NADPH is a required
cofactor for the regeneration of GSH, the most abundant low molecular
mass thiol in most organisms, by glutathione reductase along with its
critical role in the NADPH-dependent thioredoxin system [14,15]. Mito-
chondrial GSH plays a key part in protection against ROS-mediated
damage because this factor not only functions as a potent antioxidant
but is also required for the activities ofmitochondrial glutathioneperox-
idase and mitochondrial phospholipid hydroperoxide glutathione per-
oxidase [22] that removes mitochondrial peroxides. The oxidized form
of thioredoxin that contains a disulﬁde bridge between the half-
cystines can be reduced by NADPH in the presence of thioredoxin re-
ductase, a ﬂavoprotein [23]. Reduced thioredoxinmay provide reducing
equivalents to mitochondrial thioredoxin peroxidase/peroxiredoxin
family members including peroxiredoxin III/protein SP-22 [24–26] andperoxiredoxin V/AOEB166 [27]. In this regard, elevation ofmitochondri-
al NADPH and GSH by IDH2 reduces oxidative stress and suppresses
concomitant ROS-mediated cell death. To obliterate IDH2 gene expres-
sion, a speciﬁc part of the gene was removed and replaced with an arti-
ﬁcial piece of DNA (Fig. 1A). ES clones containing themutant IDH2 gene
were obtained and IDPm knock-out mice were produced as conﬁrmed
by Southern blot analysis. A 9.1-kb idh2wild-type (idh2+/+) DNA frag-
ment and 6.4-kb idh2 mutant (idh2−/−) DNA fragment were detected
(Fig. 1B). An absence of mRNA and protein expression in the idh2−/−
animals was observed with RT-PCR (Fig. 1C) and Western blot analysis
(Fig. 1D), respectively. The major 47-kDa protein band was detected in
the wild-type mice whereas the bandwas not present in the knock-out
mice. The ratio for mitochondrial [NADPH]/[NADP+/NADPH] was sig-
niﬁcantly decreased in the tissues of idh2−/− mice compared to that
from idh2+/+ mice (Fig. 1E).
3.2. B16F10 melanoma cell growth in IDH2 knock-out mice
To determine whether IDH2 deﬁciency suppresses tumor growth
in vivo, idh2+/+ and idh2−/− age-matched male mice were subcutane-
ously inoculated with B16F10 cells, a highly metastatic malignant
melanoma cell line. Fig. 2 shows thatmelanoma tumor growthwas sup-
pressed in the IDH2 knock-out animals, resulting a 5.8-fold decrease in
tumor volume and 7.2-fold decrease in tumormass relative to thewild-
typemice. Thus, an IDPm-deﬁcient tumor environment provided inhos-
pitable conditions for melanoma tumor growth.
Radiation therapy has been commonly used to treat tumors. Ionizing
radiation (IR) has been shown to generate ROS in a variety of cells [28].
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such as DNA, proteins, and lipids, eventually resulting in physical and
chemical damages that may lead to cell death [29]. We demonstrate
that IR inhibited tumor growth in both idh2+/+ and idh2−/− mice.
Tumor growth was almost completely abrogated in the idh2−/− mice
after exposure to 5 Gy of IR. Measuring tumor volume and weight is
the traditional method for monitoring tumor formation in vivo. Howev-
er, these factorsmay not be reﬂective of tumorigenesis because necrosis
and edema are disregarded when making these measurements [30]. A
bioluminescent optical imaging system with the Fluc gene has been
widely used because of its simple, noninvasive, convenient, and sensi-
tive characteristics [31]. In vivo bioluminescent and pinhole gamma
camera images were acquired after subcutaneous inoculation of each
mouse with B16F10 cells expressing the Fluc gene. As shown in Fig. 3,
bioluminescent signals from the mice reﬂected tumor growth. Data
quantiﬁcation showed that IDH2 deﬁciency resulted in a signiﬁcant in-
hibition of tumor growth. This growth was further diminished in both
idh2+/+ and idh2−/−mice upon exposure to 5 Gy of IR.
3.3. Redox status and oxidative damage to the tumors
The intracellular redox status is generally conducive for cellular
growth and proliferation, and has direct and indirect effects on different
components of cell death/survival signaling pathways [32]. To deter-
mine whether differences in tumorigenesis observed in the idh2+/+
and idh2−/−mice was associated with ROS formation, the levels of in-
tracellular H2O2 in the tumor tissues were measured with xylenol or-
ange. As shown in Fig. 4A, a signiﬁcantly higher level of intracellular
H2O2 was observed in the tumor tissue of idh2−/− mice compared to
that of idh2+/+ mice. The steady-state levels of H2O2 were further in-
creased in the tumor tissue of both idh2+/+ and idh2−/−mice following
exposure to 5 Gy of IR.- + - +
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Western blotting to analyze theprotein expression of cell cyclemarkers. (B) Tumor lysates conta
immunoblot analysis using antibodies speciﬁc for angiogenesis markers. (C) Levels of HIF-1α,
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immunoblot analysis using antibodies against glycolytic metabolism factors. (E) 2-DEmap of tu
immobilized pH 4–7 IPG strip, and separated again on a 10–16% polyacrylamide gel. (F) Intens
nase, lactate dehydrogenase, and triosephosphate isomerase in the tumor tissue from idh2−/−Protein oxidation and lipid peroxidation were also evaluated as
markers of oxidative damage to cells.Whenwemeasured carbonyl con-
tents tomonitor protein oxidation, tumor tissues from the idh2−/−mice
had an approximately 2-fold increase of carbonyl groups compared to
those from idh2+/+ mice. Protein oxidation was further increased with
the exposure of 5 Gy of IR in both idh2+/+ and idh2−/−mice (Fig. 4B).
It is well known that oxidative stress in various cells usually leads to
the accumulation of cytotoxic lipid peroxides and their breakdown
products such as MDA and 4-hydroxynonenal [33]. As shown in
Fig. 4C, lipid peroxidation measured as TBARS in the tumor tissue
from idh2−/− mice was signiﬁcantly higher than that of the idh2+/+
mice. Lipid peroxidation was further increased by exposure to 5 Gy of
IR in both idh2+/+ and idh2−/−mice. Similar results were also observed
for the HNE protein adducts analysis by immunoblotting with an anti-
HNE antibody (Fig. 4D).3.4. Modulation of tumorigenesis marker expression
At higher ROS levels, cell division is stalled and the cells undergo ap-
optosis after prolonged arrest [34]. p53 becomes activated by oxidative
stress, binds to DNA, and activates the expression of several genes
including p21, a protein that arrests cancer cells in the G1 phase and
modulates the kinase activities of various cyclin-dependent kinases
[35,36]. As shown in Fig. 5A, Western blot analysis revealed that the
amount of p21 and phosphorylated p53 was increased in tumor tissues
from the idh2−/−mice compared to those from idh2+/+mice. It was re-
cently demonstrated that the forced expression of cyclin D3 inhibits
skin tumorigenesis, indicating that cyclin D3 and cyclin D2 play oppos-
ing roles in mouse skin carcinogenesis [37]. The expression of cyclin D3
was markedly increased in tumor tissues from the idh2−/− mice
compared to those from idh2+/+ mice.- + - +
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141S. Kim et al. / Biochimica et Biophysica Acta 1842 (2014) 135–143Hypoxia-inducible factor-1 (HIF-1) has been identiﬁed as a master
transcription regulator that holds important roles in development,
physiology, andmany pathological processes including cancer develop-
ment [38,39]. Many of the genes that are direct targets of HIF-1α are in-
volved in angiogenesis, metabolic adaptation, apoptosis, and invasion/
metastasis [40]. Genetic alterations in signal transduction pathways
are highly variable among human tumors, but increased expression of
HIF-1αmay represent a common ﬁnal pathway in tumorigenesis [41].
Thus, HIF-1α-mediated angiogenesis and metabolic adaptation may
play critical roles in tumor progression. The protein levels of HIF-1α in
tumor tissues from idh2+/+ and idh2−/−micewere examined by immu-
noblotting. HIF-1α accumulation in the tumor tissue from idh2−/−mice
was signiﬁcantly reduced compared to that observed in idh2+/+ mice.
Furthermore, tumor tissues from the idh2−/−mice had reduced expres-
sion of VEGF, a known target of HIF-1α.
The phosphatidylinositol 3-kinase (PI3K)/Akt pathway is constitu-
tively activated in human tumor cells, resulting in increased expression
of HIF-1α through activation of Sp1 [42,43]. Akt, a serine-threonine ki-
nase and downstream target of PI3K, is regulated by phosphoinositide-
dependent protein kinases (PDKs) [44]. Akt phosphorylation in tumor
tissues from the idh2−/− mice was signiﬁcantly reduced compared to
those from idh2+/+mice (Fig. 5B). Consistent withWestern blot analy-
sis showing that tumor tissues from idh2−/−mice had signiﬁcantly de-
creased HIF-1α expression, blunted mRNA expression of HIF-1α, VEGF,
and the glucose transport protein Glut-1 was also observed (Fig. 5C).
A universally observed clinical phenotype of highly malignant tu-
mors is the propensity to rapidly proliferate and spread within a
tumor-bearing host [42]. One molecular strategy underlying this char-
acteristic is the tumor's ability to consume glucose at abnormally high
rates. The key sub-cellular and molecular players that propel this0
1
2
3
4
WT KO
0
0.5
1
1.5
2
n
m
o
l M
D
A
/m
g 
pr
ot
ei
n*
WT K
WT KO
VEGF
IDH2 β-actin
HIF-1α
pAkt
VEGF
βFGF
HIF-1α
R
el
at
iv
e 
m
R
N
A
 le
ve
l
A B
D
WT KO
E
β-actin
μm
o
l H
2O
2/m
g 
pr
ot
ei
n
Fig. 6.Modulation of redox status and angiogenesis marker expression in the stroma of idh2+/+
xylenol orange. Each value represents themean ± S.D. from ﬁve or six independent experimen
was determined using a TBARS assay. Each value represents the mean ± S.D. from ﬁve or six in
and glutathionylated adducts in the stromal tissue extracts weremeasured with an anti-HNEMic
lysates containing equal amounts of protein (20 μg)were separated by SDS-PAGE and then subje
VEGF, and βFGF mRNA levels were measured by RT-PCR, normalized to β-actin mRNA, and are
of VEGF in idh2+/+ and idh2−/−mice were analyzed using a mouse VEGF ELISA kit. Each valu
the idh2+/+ mice.metabolic transformation can be distilled to a few select enzymes, nota-
bly hexokinase and several mitochondria-associated enzymes [45]. As
shown in Fig. 5D, a Western blot analysis revealed that the expression
levels of hexokinase I, hexokinase II, and pyruvate dehydrogenase
were markedly decreased in tumor tissue from the idh2−/−mice com-
pared to those from the idh2+/+ mice.
To further investigate alterations in the expression of genes with
roles in glycolytic metabolism, we carried out a proteomic analysis of
tumor tissues from the idh2+/+ and idh2−/−mice. Differential proteo-
mic analysis by 2-DE of the soluble protein fraction from the tumor tis-
sues was performed. Representative 2-DE gel images are shown in
Fig. 5E. Proteinswere subsequently identiﬁed byMALDI-TOFMS includ-
ing key enzymes involved in glycolytic metabolism (Fig. 5F). Down-
regulated expression of enolase 1, glycerol 3-phosphate dehydroge-
nase, pyruvate kinase, lactate dehydrogenase, and triosephosphate
isomerase was observed, indicating that the reduction of glycolytic me-
tabolism may be associated with the suppression of tumor growth in
the idh2+/+ mice.
3.5. Modulation of redox status and angiogenesis marker expression in the
tumor stroma
The importance of cellular context as a factor that drives tumorigen-
esis has led to the hypothesis that the stroma surrounding tumors ex-
erts a tissue modiﬁcation ﬁeld effect that promotes the development
and progression of epithelial malignancies [2,46]. Possible mechanisms
underlying the tumor suppression associated with IDH2 deﬁciency
could be enhanced oxidative stress and decreased tumor angiogenesis.
Therefore, we attempted to clarify the response of the host microenvi-
ronment to metastatic cancer cells. To assess the difference in ROS*
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142 S. Kim et al. / Biochimica et Biophysica Acta 1842 (2014) 135–143formation in the idh2+/+ and idh2−/− mice, the levels of intracellular
H2O2 in the stromal tissues were evaluated. As shown in Fig. 6A, IDPm
deﬁciency was accompanied by substantial elevations of intracellular
H2O2 levels in the stromal tissue measured by xylenol orange.
As indicativemarkers of oxidative damage to cells, lipid peroxidation
and protein oxidation were also evaluated. As shown in Fig. 6B, lipid
peroxidation measured as TBARS in the stromal tissue of idh2−/−mice
was signiﬁcantly higher than that of the idh2+/+ mice. Similar results
were also observed for the HNE protein adduct analysis using an anti-
HNE antibody (Fig. 6C). Levels of oxidative protein damage were mea-
sured by determining the number of derivatized carbonyl groups on ox-
idized proteins from the stroma lysates byWestern blotting for oxidized
protein carbonyl groups. Data from this analysis showed an increase in
oxidative protein damage in stromal tissues from the idh2−/− mice
compared to those from idh2+/+ mice. There are numerous oxidative
stress-induced conditions during which the redox status and GSH/
GSSG ratio are perturbed [47]. Protein S-glutathionylation is a post-
translational modiﬁcation of protein sulfhydryl groups that occurs
under oxidative stress [48]. As shown in Fig. 6C, Western blot analysis
of stromal lysates with an anti-GSH IgG revealed a signiﬁcant increase
of glutathionylated proteins in the stroma tissues from idh2−/− mice.
Taken together, our ﬁndings indicated that excessive production of
ROS in the stroma may elicit a bystander effect, leading to oxidative
stress and cell death in adjacent cancer cells.
For many cancer treatments, cytotoxic ROS have been extensively
used to kill tumor cells that are equipped with a weaker antioxidant
defense system thannormal cells [9,49].We sought to characterize the al-
tered expression of factors capable of inﬂuencing cancer cell invasion and
metastasis. The protein levels of HIF-1α, VEGF, and p-Akt in stromal tis-
sues from idh2+/+ and idh2−/− mice were examined by immunoblot
analysis. As shown in Fig. 6D, accumulation of these angiogenesis
markers in the stromal tissue of idh2−/−mice was signiﬁcantly reduced
compared to that from idh2+/+ mice. Consistent with the Western blot
results, stromal tissue from the idh2−/−mice also had signiﬁcantly de-
creased HIF-1α, VEGF, and βFGF mRNA levels (Fig. 6E). Furthermore,
plasma levels of VEGF in the idh2−/− mice were markedly lower com-
pared to those of the idh2+/+mice (Fig. 6F). Taken together, our ﬁndings
showed that down-regulated expression of angiogenesismarkers creates
an environment undesirable for tumor survival and growth. Previously,
we have shown that inhibition of the PI3K/Akt pathway in IDH2 knock-
down cells results in the inhibition of HIF-1αmRNA expression [50].
In summary, we demonstrated that tumorigenesis is suppressed in
mice deﬁcient in IDH2, which is accompanied by a signiﬁcant elevation
of oxidative stress and decreased expression of angiogenesis markers in
both the tumor and stroma. These results indicate that the process of tu-
morigenesis may be inﬂuenced by interactions between intrinsic alter-
ations of tumor cells and the extrinsic microenvironment. Our ﬁndings
support the hypothesis that changes of redox status in the stromalmicro-
environment may contribute to the progression of melanoma neoplasia.
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